Published in Am J Pathol on November 01, 2003
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound. BMC Cancer (2008) 1.10
MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Rev Mol Diagn (2009) 1.02
Identification and characterization of a novel estrogenic ligand actinopolymorphol A. Biochem Pharmacol (2010) 0.99
Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. Carcinogenesis (2010) 0.94
Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models. Breast Cancer Res (2008) 0.93
Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content. Mol Endocrinol (2011) 0.92
Mouse models of estrogen receptor-positive breast cancer. J Carcinog (2011) 0.91
Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res (2010) 0.90
Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. BMC Cancer (2009) 0.87
Wnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model. Cancer Lett (2009) 0.84
Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD. J Cell Physiol (2010) 0.84
Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland. Dev Biol (2014) 0.82
Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models. Ann N Y Acad Sci (2011) 0.81
A mouse model for luminal epithelial like ER positive subtype of human breast cancer. BMC Cancer (2007) 0.80
Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice. Oncogene (2009) 0.77
Genetically engineered ERα-positive breast cancer mouse models. Endocr Relat Cancer (2014) 0.77
Primary cancer cell culture: mammary-optimized vs conditional reprogramming. Endocr Relat Cancer (2016) 0.75
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell (2002) 4.36
Hormonal carcinogenesis. Carcinogenesis (2000) 3.86
A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A (1995) 3.80
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med (2001) 3.51
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J (2002) 3.05
Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol (1999) 2.52
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev (2003) 2.27
Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol (1978) 1.99
Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia (1998) 1.97
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82
Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr (2000) 1.53
The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol (1998) 1.40
Prognostic and predictive factors in breast cancer. Cancer Treat Rev (2001) 1.38
Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol (1995) 1.25
Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat (1994) 0.96
Estrogen receptor alpha in mouse splenic lymphocytes: possible involvement in immunity. Toxicol Lett (2002) 0.95
17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. Endocrinology (1980) 0.94
Mouse models for breast cancer. Oncogene (2000) 0.94
A simplified method to prepare PCR template DNA for screening of transgenic and knockout mice. Contemp Top Lab Anim Sci (2001) 0.90
Conditional over-expression of estrogen receptor alpha in a transgenic mouse model. Transgenic Res (2002) 0.90
Conditional control of gene expression in the mammary gland. J Mammary Gland Biol Neoplasia (1997) 0.87
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 10.49
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst (2003) 8.66
MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat (2006) 4.04
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med (2007) 3.36
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat (2005) 2.30
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab (2007) 2.21
Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol (2006) 1.88
Characterization of matriptase expression in normal human tissues. J Histochem Cytochem (2003) 1.74
Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc Natl Acad Sci U S A (2007) 1.71
Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim (2004) 1.71
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem (2003) 1.71
Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol (2003) 1.63
Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61
Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer (2004) 1.60
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol (2005) 1.56
BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development (2003) 1.55
Body mass and stage of breast cancer at diagnosis. Int J Cancer (2002) 1.54
The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res (2008) 1.53
The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol (2005) 1.52
Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development (2003) 1.49
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res (2005) 1.46
The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency. Am J Pathol (2013) 1.45
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res (2002) 1.44
Personal characteristics, knowledge of the veterinary profession, and influences on career choice among students in the veterinary school applicant pool. J Am Vet Med Assoc (2003) 1.43
Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway. Toxicol Sci (2006) 1.40
Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics (2003) 1.39
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev (2008) 1.38
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene (2002) 1.30
Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem (2012) 1.29
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis (2004) 1.29
Methoxychlor metabolites may cause ovarian toxicity through estrogen-regulated pathways. Toxicol Sci (2006) 1.28
Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am J Physiol Cell Physiol (2009) 1.27
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am J Physiol Cell Physiol (2007) 1.27
Bisphenol A impairs follicle growth, inhibits steroidogenesis, and downregulates rate-limiting enzymes in the estradiol biosynthesis pathway. Toxicol Sci (2010) 1.26
Active properties of motoneurone dendrites: diffuse descending neuromodulation, focused local inhibition. J Physiol (2007) 1.26
The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol (2008) 1.25
Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol (2005) 1.25
Intrinsic electrical properties of spinal motoneurons vary with joint angle. Nat Neurosci (2007) 1.24
Matriptase activation, an early cellular response to acidosis. J Biol Chem (2009) 1.24
Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front Biosci (2008) 1.24
Methoxychlor directly affects ovarian antral follicle growth and atresia through Bcl-2- and Bax-mediated pathways. Toxicol Sci (2005) 1.24
Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol (2005) 1.22
Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene (2002) 1.22
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene (2005) 1.19
Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation. J Biol Chem (2010) 1.19
Real-time imaging and characterization of human breast tissue by reflectance confocal microscopy. J Biomed Opt (2007) 1.17
Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod (2002) 1.17
Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas (2006) 1.16
In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate (2006) 1.14
A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia (2008) 1.12
Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) (2003) 1.12
Acute and chronic effects of oral genistein administration in neonatal mice. Biol Reprod (2010) 1.12
Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med (2002) 1.11
Personality and citizenship behavior: the mediating role of job satisfaction. J Appl Psychol (2009) 1.11
Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound. BMC Cancer (2008) 1.10
Differences between rats and mice in the involvement of the aryl hydrocarbon receptor in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss. Toxicol Appl Pharmacol (2005) 1.10
Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicol Appl Pharmacol (2011) 1.09
Association between race and hot flashes in midlife women. Maturitas (2006) 1.08
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol (2005) 1.08
Physical activity and risk of hot flashes among women in midlife. J Womens Health (Larchmt) (2007) 1.07
Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia (2004) 1.07
Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. Am J Physiol Cell Physiol (2006) 1.06
Active dendritic integration of inhibitory synaptic inputs in vivo. J Neurophysiol (2003) 1.06
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Res Treat (2008) 1.06
Ovarian follicle development requires Smad3. Mol Endocrinol (2004) 1.06
Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle (2006) 1.06
Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat (2008) 1.06
Depressive symptoms and self-reported fast-food intake in midlife women. Prev Med (2011) 1.06
Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicol Appl Pharmacol (2009) 1.05
Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDS (2005) 1.04
Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril (2006) 1.04
PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene (2005) 1.03
Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PLoS One (2009) 1.03
Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas (2009) 1.02
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor. Bioorg Med Chem Lett (2007) 1.02
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction (2011) 1.01
Methoxychlor-induced atresia in the mouse involves Bcl-2 family members, but not gonadotropins or estradiol. Biol Reprod (2004) 1.00
Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol Endocrinol (2004) 1.00
Bisphenol A inhibits follicle growth and induces atresia in cultured mouse antral follicles independently of the genomic estrogenic pathway. Biol Reprod (2012) 0.99
The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness. Biol Reprod (2007) 0.98
In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol (2004) 0.98
Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res (2007) 0.98
TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol (2010) 0.97
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation. Breast Cancer Res Treat (2012) 0.95
Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biol Reprod (2002) 0.95
Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett (2005) 0.95
NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res B Dev Reprod Toxicol (2006) 0.95
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt) (2013) 0.95
GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate (2006) 0.94